Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano‐Immunoadjuvant

Jingjing Wei, Di Wu, Songsong Zhao, Yu Shao, Yifeng Xia, Dawei Ni, Xinyun Qiu, Jinping Zhang, Jian Chen, Fenghua Meng, Zhiyuan Zhong

Open source

DOI: 10.1002/advs.202103689
Published: 2022-03-07
Container: Advanced Science
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/advs.202103689,
  title = {Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano‐Immunoadjuvant},
  author = {Jingjing Wei and Di Wu and Songsong Zhao and Yu Shao and Yifeng Xia and Dawei Ni and Xinyun Qiu and Jinping Zhang and Jian Chen and Fenghua Meng and Zhiyuan Zhong},
  year = {2022},
  journal = {Advanced Science},
  doi = {10.1002/advs.202103689},
  url = {https://doi.org/10.1002/advs.202103689}
}

RIS

TY  - JOUR
TI  - Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano‐Immunoadjuvant
AU  - Jingjing Wei
AU  - Di Wu
AU  - Songsong Zhao
AU  - Yu Shao
AU  - Yifeng Xia
AU  - Dawei Ni
AU  - Xinyun Qiu
AU  - Jinping Zhang
AU  - Jian Chen
AU  - Fenghua Meng
AU  - Zhiyuan Zhong
PY  - 2022
JO  - Advanced Science
DO  - 10.1002/advs.202103689
UR  - https://doi.org/10.1002/advs.202103689
ER  -

APA

Wei, J., Wu, D., Zhao, S., Shao, Y., Xia, Y., Ni, D., Qiu, X., Zhang, J., Chen, J., Meng, F., & Zhong, Z. (2022). Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano‐Immunoadjuvant. Advanced Science. https://doi.org/10.1002/advs.202103689

Source records

crossref · retrieved 2026-09-25T12:01:42.841Z